Compare SAFE & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SAFE | INSP |
|---|---|---|
| Founded | 2016 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 1999 | 2018 |
| Metric | SAFE | INSP |
|---|---|---|
| Price | $16.19 | $60.09 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 16 |
| Target Price | $19.00 | ★ $94.00 |
| AVG Volume (30 Days) | 274.0K | ★ 890.2K |
| Earning Date | 04-30-2026 | 05-04-2026 |
| Dividend Yield | ★ 4.48% | N/A |
| EPS Growth | 7.43 | ★ 179.43 |
| EPS | ★ 0.82 | N/A |
| Revenue | ★ $385,552,000.00 | $82,050,000.00 |
| Revenue This Year | N/A | $8.02 |
| Revenue Next Year | $4.31 | $8.11 |
| P/E Ratio | $20.01 | ★ N/A |
| Revenue Growth | 5.43 | ★ 62.18 |
| 52 Week Low | $12.76 | $38.91 |
| 52 Week High | $17.45 | $147.03 |
| Indicator | SAFE | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 48.86 | 66.87 |
| Support Level | $13.99 | $57.57 |
| Resistance Level | $16.54 | $86.00 |
| Average True Range (ATR) | 0.49 | 2.61 |
| MACD | -0.07 | 0.83 |
| Stochastic Oscillator | 25.00 | 67.46 |
Safehold Inc is a REIT that operates its business by acquiring, managing, and capitalizing ground leases. Ground leases are long-term contracts between the landlord (the Company) and a tenant or leaseholder. Ground leases generally represent ownership of the land underlying commercial real estate projects that are net leased by the fee owner of the land to the owners/operators of the real estate projects built thereon.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.